Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Randy Boldyga
Randy Boldyga
CEO, President & Founder
RXNT
2024-05-11

RXNT stands at the forefront of cloud computing technology after anticipating the shift towards cloud-based solutions early on.

READ MORE
Takashi Toraishi
Takashi Toraishi
Co-CEO & President
Rakuten Medical
2024-05-11

Our technology is a platform technology, meaning we believe it can be adapted to target various cancers by switching the cell-targeting moiety.

READ MORE
Helmy Eltoukhy
Helmy Eltoukhy
Co-Founder, Chairman & Co-CEO
Guardant Health
2024-05-11

Guardant Health has developed a portfolio of tests that revolutionize cancer care, beginning with Guardant360, the world’s first FDA-approved liquid biopsy for therapy selection in advanced-stage cancer patients.

READ MORE
Mark Herbert
Mark Herbert
VP of Biopharma Business Development
Varda Space Industries
2024-05-11

Varda is committed to supporting the entire biopharmaceutical industry, including both small molecules and biologics.  The company's current capabilities encompass small molecule melt cool and solvent-based applications, both terrestrially and in flight, with a focus on expanding into biologic-based applications in the future.

READ MORE
Priya Abani
Priya Abani
President & CEO
AliveCor
2024-05-11

AliveCor has entered collaborations with CROs and biopharma companies including Novartis and Bristol Myers Squibb to support decentralized clinical trials and patient safety monitoring.

READ MORE
Robert Spignesi
Robert Spignesi
President & CEO
Rapid Micro Biosystems
2024-05-11

We have introduced and plan to continue development of new technologies that leverage our expertise in automated microbial testing, coupled with advances in AI and software to enhance microbial detection and differentiation capabilities.

READ MORE
Adam Schechter
Adam Schechter
Chairman & CEO
Labcorp
2024-05-11

Labcorp's diagnostic segment is dynamic, with over 6,500 tests that span across all therapeutic areas. Our focus is on areas with significant technological advancements such as oncology, neurology, women's health, and autoimmune diseases.

READ MORE
Jim Hollingshead
Jim Hollingshead
President & CEO
Insulet
2024-05-11

Unlike previous generations and competing tubed pumps, Omnipod 5's automated dosing algorithm significantly reduces the need for manual insulin adjustments, enhancing both convenience and clinical outcomes.

READ MORE
Philip Ma
Philip Ma
CEO & Founder
PrognomiQ
2024-05-11

PrognomiQ is focused on harnessing the power of multi-omics data to transform the early detection, treatment selection and recurrence monitoring of cancer and other complex diseases. 

READ MORE
Brian Kim
Brian Kim
CEO
Mission Bio
2024-05-11

The company distinguished itself by focusing on DNA and protein analysis at the single-cell level, a capability that was unique at the time and still is.

READ MORE